fda announcement semaglutide Approves Oral Semaglutide: First GLP-1 Weight Loss Pill 🚨 FDA Ends Semaglutide Shortage

New therapies could target energy expenditure directly FGF21-like drugs may complement GLP-1s, combining appetite control and metabolic activation for better, more sustainable outcomes

Accurate volume measurement is critical

Eating protein before anything else on your plate ensures you hit minimum thresholds before fullness shuts down meals prematurely, a strategy borrowed from bariatric nutrition protocols that works when you're operating with dramatically reduced stomach capacity

Chronic oxidative stress increases the integration frequency of foreign DNA and human papillomavirus 16 in human keratinocytes

Moreover, ongoing studies such as the FOCUS trial are investigating its impact on microvascular complications